Melinda Tan

5PUBLICATIONS
26CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 12, 2026
Prophylactic dexamethasone at the time of absolute lymphocyte expansion does not mitigate risk or event-free survival for immune effector cell associated delayed neurotoxicity.

|Jun 26, 2026
Early Treatment Failure in Patients Receiving Ciltacabtagene-Autoleucel for Relapsed/Refractory Multiple Myeloma.

|Dec 16, 2025
Daratumumab bortezomib and dexamethasone in transplant ineligible newly diagnosed elderly myeloma patients (AMN006)-a trial by Asian Myeloma Network (NCT03695744).

Melinda S Y Tan, Chandramouli Nagarajan, Melissa Ooi

|Jun 12, 2024
Beyond BCMA: newer immune targets in myeloma.

Melinda S Y Tan, Yunxin Chen, Eric L Smith

Pageof 1

Frequent Collaborators

2 joint publications

J Erin Wiedmeier-Nutor

2 joint publications

Rafael Fonseca

2 joint publications

Nadine Abdallah

2 joint publications

Saurabh Zanwar